Invest2Innovate

Invest2Innovate

Invest2Innovate is structured as a private equity firm, registered in Washington, DC, with a mandate that spans the earliest phases of company formation through later growth rounds. While the founding date and principals are not publicly enumerated, the firm's name signals a direct thesis: channeling investment into innovation-stage enterprises. The vehicle operates at the intersection of venture capital and private equity, a hybrid common among smaller asset managers seeking to capture value creation from inception to scale. The investment strategy covers four explicit stages: early stage, seed, start-up, and growth. This continuum suggests a portfolio construction designed to hold positions from initial capital deployment through subsequent financing events, rather than a purely passive seed-and-sell approach. Without confirmed portfolio names, the firm's sector concentration remains undocumented, though its Washington location places it within a rich government-adjacent technology and services ecosystem that includes cybersecurity, enterprise SaaS, and health IT. Operational scale is opaque. No headcount, AUM, or cumulative deployment figures have been disclosed publicly, and the firm does not appear to maintain an active LinkedIn presence. Its web domain, i2iventures.com, suggests the invest-to-innovate thesis is also the firm's public brand identity, yet no scraped site content was available for verification of team biographies, portfolio companies, or limited partner base. As a small, unlisted private equity firm with no disclosed track record or named leadership, Invest2Innovate's structural differentiator is difficult to isolate. Its stage-agnostic mandate — seed to growth within a single fund structure — would, if executed, create a uniquely concentrated exposure for investors, compressing the typical venture-to-growth handoff into one manager relationship.